Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Antares Pharma Inc.

    NASDAQ: ATRS · Real-Time Price · USD
    5.59
    0.01 (0.18%)
    At close: Apr 24, 2025, 3:47 PM

    Antares Pharma Statistics

    Share Statistics

    Antares Pharma has 0 shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 4.78M, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.78M

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1.25

    Valuation Ratios

    The PE ratio is 13.12 and the forward PE ratio is null. Antares Pharma's PEG ratio is -0.72.

    PE Ratio

    n/a
    		 13.12

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 3.3

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 3.46

    P/FCF Ratio

    n/a
    		 20.25

    PEG Ratio

    n/a
    		 -0.72
    Financial Ratio History

    Enterprise Valuation

    Antares Pharma has an Enterprise Value (EV) of 565.49M.

    EV / Sales

    n/a
    		 3.07

    EV / EBITDA

    n/a
    		 8.55

    EV / EBIT

    n/a
    		 15.44

    EV / FCF

    n/a
    		 18.85

    Financial Position

    The company has a current ratio of 2.74, with a Debt / Equity ratio of 0.14.

    Current Ratio

    n/a
    		 2.74

    Quick Ratio

    n/a
    		 2.55

    Debt / Equity

    n/a
    		 0.14

    Debt / EBITDA

    n/a
    		 0.36

    Debt / FCF

    n/a
    		 0.8

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 26.34% and Return on Invested Capital is 25.02%.

    Return on Equity

    n/a
    		 26.34%

    Return on Assets

    n/a
    		 17.98%

    Return on Invested Capital

    n/a
    		 25.02%

    Revenue Per Employee

    n/a
    		 $915,333.33

    Profits Per Employee

    n/a
    		 $230,293.53

    Employee Count

    n/a
    		 201

    Asset Turnover

    n/a
    		 0.71

    Inventory Turnover

    n/a
    		 5.91

    Taxes

    Income Tax

    n/a
    		 15.98M

    Effective Tax Rate

    n/a
    		 25.67%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.15, so Antares Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.15

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 4.86

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 78.69

    Average Volume (20 Days)

    n/a
    		 5,230,217

    Income Statement

    In the last 12 months, Antares Pharma had revenue of 183.98M and earned 46.29M in profits. Earnings per share was 0.27.

    Revenue

    n/a
    		 183.98M

    Gross Profit

    n/a
    		 115.7M

    Operating Income

    n/a
    		 62.27M

    Net Income

    n/a
    		 46.29M

    EBITDA

    n/a
    		 66.17M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 0.27
    Full Income Statement

    Balance Sheet

    The company has 65.91M in cash and 23.95M in debt, giving a net cash position of 41.96M.

    Cash & Cash Equivalents

    n/a
    		 65.91M

    Total Debt

    n/a
    		 23.95M

    Net Cash

    n/a
    		 41.96M

    Retained Earnings

    n/a
    		 -176.34M

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 36.62M and capital expenditures -6.62M, giving a free cash flow of 30M.

    Operating Cash Flow

    n/a
    		 36.62M

    Capital Expenditures

    n/a
    		 -6.62M

    Free Cash Flow

    n/a
    		 30M

    FCF Per Share

    n/a
    		 0.18
    Full Cash Flow Statement

    Margins

    Gross margin is 62.89%, with operating and profit margins of 33.85% and 25.16%.

    Gross Margin

    n/a
    		 62.89%

    Operating Margin

    n/a
    		 33.85%

    Pretax Margin

    n/a
    		 33.85%

    Profit Margin

    n/a
    		 25.16%

    EBITDA Margin

    n/a
    		 35.97%

    EBIT Margin

    n/a
    		 33.85%

    FCF Margin

    n/a
    		 16.31%

    Dividends & Yields

    ATRS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 7.62%

    FCF Yield

    n/a
    		 4.94%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ATRS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 2.51

    Graham Upside

    n/a
    		 -55.1%

    Stock Splits

    The last stock split was on Jan 29, 1999. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Jan 29, 1999

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist